DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+109.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$431M
AUM Growth
+$25.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
87
New
Increased
Reduced
Closed

Top Buys

1
+$8.92M
2
+$3.98M
3
+$2.93M
4
DNLI icon
Denali Therapeutics
DNLI
+$2.53M
5
MPLT
MapLight Therapeutics
MPLT
+$2.41M

Top Sells

1
+$20.8M
2
+$7.45M
3
+$6.53M
4
IBB icon
iShares Biotechnology ETF
IBB
+$5.59M
5
RCUS icon
Arcus Biosciences
RCUS
+$4M

Sector Composition

1 Healthcare 86.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$33.5B
$48.1M 11.18%
604,514
-52,662
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$8.54B
$41M 9.53%
336,505
-65,000
STXS icon
3
Stereotaxis
STXS
$194M
$31.5M 7.31%
13,680,554
ATRC icon
4
AtriCure
ATRC
$1.4B
$23.6M 5.49%
597,431
+5,158
CYTK icon
5
Cytokinetics
CYTK
$10.4B
$23.6M 5.48%
370,997
-23,943
IDYA icon
6
IDEAYA Biosciences
IDYA
$2.59B
$17.5M 4.07%
506,740
-33,183
AXGN icon
7
Axogen
AXGN
$2.1B
$15.6M 3.63%
476,826
-265,456
XENE icon
8
Xenon Pharmaceuticals
XENE
$5.29B
$12.9M 3%
287,939
IBB icon
9
iShares Biotechnology ETF
IBB
$8.05B
$11.5M 2.67%
68,095
-34,405
BHVN icon
10
Biohaven
BHVN
$1.66B
$10.8M 2.51%
955,235
+720,000
RCUS icon
11
Arcus Biosciences
RCUS
$3.19B
$10.3M 2.39%
431,329
-196,297
NBIX icon
12
Neurocrine Biosciences
NBIX
$15.9B
$10M 2.33%
70,615
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
$9.31M 2.16%
999,163
TNDM icon
14
Tandem Diabetes Care
TNDM
$1.18B
$7.81M 1.81%
355,208
ASND icon
15
Ascendis Pharma A/S
ASND
$13.8B
$6.01M 1.4%
28,177
-5,000
DXCM icon
16
DexCom
DXCM
$28.5B
$5.86M 1.36%
88,279
+22,727
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.74B
$5.84M 1.36%
277,855
-222,847
KALV icon
18
KalVista Pharmaceuticals
KALV
$1.43B
$5.76M 1.34%
356,802
-65,929
CMPS
19
Compass Pathways
CMPS
$1.76B
$5.6M 1.3%
811,046
INGN icon
20
Inogen
INGN
$176M
$5.56M 1.29%
827,071
+221,446
DNLI icon
21
Denali Therapeutics
DNLI
$3.34B
$5.26M 1.22%
318,500
+150,000
MBX
22
MBX Biosciences
MBX
$1.5B
$5.21M 1.21%
165,265
+80,265
BCAX
23
Bicara Therapeutics
BCAX
$1.43B
$4.4M 1.02%
261,583
-55,418
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.87B
$4.26M 0.99%
130,175
ATXS
25
DELISTED
Astria Therapeutics
ATXS
$3.99M 0.93%
304,775
-15,000
1
2 3 4